Long-term effect of chemotherapy-intensity-modulated radiation therapy (chemo-IMRT) on dentofacial development in head and neck rhabdomyosarcoma patients.
Dentofacial developmental abnormalities have been reported in head and neck rhabdomyosarcoma (HNRMS) patients treated with conventional radiotherapy technique and chemotherapy. This current study investigates dentofacial long-term effects among HNRMS survivors managed with intensity-modulated radiotherapy (IMRT) and chemotherapy. In general, IMRT is a more effective 3D-conformal radiotherapy technique, which delivers high doses of radiation to the tumor target while minimizing doses received by the surrounding normal tissues. The medical records and radiographs of thirteen patients were reviewed to identify the following: 1. Facial asymmetry and jaw hypoplasia. 2. Effects on the dental tissue causing tooth agenesis/hypodontia, root agenesis/stunting/malformation, and/or enamel hypoplasia. 3. Trismus, hyposalivation/xerostomia. Seven patients presented with facial asymmetry and jaw hypoplasia, 9 patients presented with effects on the dental tissue [root agenesis/stunting/malformation (9), tooth agenesis/hypodontia (7) and enamel hypoplasia (3)] and 7 patients developed trismus and /or xerostomia. All patients with facial asymmetry and jaw hypoplasia also developed dental abnormalities. Patients with dentofacial developmental abnormalities were ≤7 years of age at treatment. Our study shows that dentofacial developmental abnormalities are still a burden in the era of IMRT and as prognosis of childhood malignancy improves and more patients survive, these late dentofacial sequelae among childhood cancer survivors will become more common. Dental oncologists should be integral members in the management of children with head and neck cancers.
a Department of Surgery , Memorial Sloan Kettering Cancer Center , New York, New York , USA.
Adepitan A
AA
Owosho
b Department of Radiation Oncology , Memorial Sloan Kettering Cancer Center , New York, New York , USA.
Paul
P
Brady
b Department of Radiation Oncology , Memorial Sloan Kettering Cancer Center , New York, New York , USA.
Suzanne L
SL
Wolden
c Department of Pediatrics , Memorial Sloan Kettering Cancer Center , New York, New York , USA.
Leonard H
LH
Wexler
d Department of Pathology , Memorial Sloan Kettering Cancer Center , New York, New York , USA.
Cristina R
CR
Antonescu
a Department of Surgery , Memorial Sloan Kettering Cancer Center , New York, New York , USA.
Joseph M
JM
Huryn
a Department of Surgery , Memorial Sloan Kettering Cancer Center , New York, New York , USA.
Cherry L
CL
Estilo
D059248:Chemoradiotherapy / Q000009:adverse effects*; D002675:Child, Preschool; D063169:Dentofacial Deformities; D005146:Facial Asymmetry / Q000209:etiology / Q000401:mortality / Q000517:prevention & control; D005260:Female; D006258:Head and Neck Neoplasms / Q000401:mortality / Q000628:therapy; D006801:Humans; D007223:Infant; D007569:Jaw Abnormalities / Q000209:etiology / Q000401:mortality / Q000517:prevention & control; D008297:Male; D012208:Rhabdomyosarcoma / Q000401:mortality / Q000628:therapy; D013997:Time Factors
Chemotherapy; IMRT; dentofacial developmental abnormalities; head and neck rhabdomyosarcoma
Cancer. 2009 Sep 15;115(18):4218-26
19536876
Med Pediatr Oncol. 1999 Oct;33(4):362-71
10491544
Oral Oncol. 2002 Jul;38(5):450-9
12110339
Oral Surg Oral Med Oral Pathol. 1984 Jun;57(6):595-9
6588339
AJR Am J Roentgenol. 1994 Jun;162(6):1407-11
8192008
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Dec;104(6):781-9
17618135
Semin Radiat Oncol. 1997 Jul;7(3):212-216
10717216
Eur J Cancer. 2003 Nov;39(16):2349-54
14556927
Support Care Cancer. 2014 Jul;22(7):2009-19
24781353
Leukemia. 1997 Jun;11(6):792-6
9177429
Acta Odontol Scand. 1985 Jul;43(3):155-62
3864334
Scand J Dent Res. 1980 Apr;88(2):104-12
6929558
Int J Paediatr Dent. 2012 Jul;22(4):239-43
22092748
J Clin Oncol. 1995 Aug;13(8):2123-39
7636557
Pediatr Dent. 1993 Jan-Feb;15(1):6-12
8233995
Radiother Oncol. 2014 Oct;113(1):77-83
25443861
Med Pediatr Oncol. 1995 Aug;25(2):96-101
7603407
Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):179-86
19019562
Eur J Oral Sci. 2004 Feb;112(1):8-11
14871187
Cancer. 2000 Aug 1;89(3):690-5
10931470
Pediatr Blood Cancer. 2006 Apr;46(4):454-8
16200569
Cancer. 1986 May 15;57(10):2070-6
3955515
Pediatr Hematol Oncol. 2005 Oct-Nov;22(7):581-8
16166051
Cancer. 1990 Dec 15;66(12):2645-52
2249205
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Mar;87(3):317-21
10102592
Cancer. 1987 Nov 15;60(10):2570-5
3664436
Cancer Res. 1975 Aug;35(8):2199-202
1149033
Otolaryngol Head Neck Surg. 2011 Dec;145(6):967-73
21873599
J Pediatr Hematol Oncol. 2003 Mar;25(3):215-22
12621240
Arch Dis Child. 1984 Dec;59(12):1186-7
6524952
Pediatrics. 1984 Jun;73(6):816-23
6728583
Pediatr Blood Cancer. 2009 Sep;53(3):361-5
19484760
Cell Tissue Res. 1983;234(3):679-89
6661756
Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Aug;114(2):e50-4
22769422
Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1489-95
11121653
Pediatr Blood Cancer. 2014 Mar;61(3):407-16
24424790
Cancer. 2009 Dec 15;115(24):5817-27
19834960
Med Pediatr Oncol. 1998 Jan;30(1):22-7
9371385